FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

8 results

abilify
(ARIPIPRAZOLE)
Otsuka America Pharmaceutical, Inc.
Usage: ABILIFY (aripiprazole) is indicated for the treatment of schizophrenia, acute manic and mixed episodes associated with Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and treatment of Tourette's disorder.
abilify maintena
(aripiprazole)
Otsuka America Pharmaceutical, Inc.
Usage: ABILIFY MAINTENA (aripiprazole) is indicated for the treatment of schizophrenia and as maintenance monotherapy for bipolar I disorder in adults.
abilify mycite
(ARIPIPRAZOLE)
Otsuka America Pharmaceutical, Inc.
Usage: ABILIFY MYCITE is indicated for treating adults with schizophrenia, bipolar I disorder (including both acute and maintenance phases), and as adjunctive therapy for Major Depressive Disorder. It features an Ingestible Event Marker (IEM) sensor to track medication ingestion.
busulfex
(busulfan)
Otsuka America Pharmaceutical, Inc.
Usage: BUSULFEX is indicated for use alongside cyclophosphamide as a conditioning regimen before allogeneic hematopoietic progenitor cell transplantation in patients with chronic myelogenous leukemia.
jynarque
(tolvaptan)
Otsuka America Pharmaceutical, Inc.
Usage: JYNARQUE is indicated to slow the decline of kidney function in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).
rexulti
(brexpiprazole)
Otsuka America Pharmaceutical, Inc.
Usage: REXULTI is indicated as an adjunctive treatment for major depressive disorder in adults, for the treatment of schizophrenia in adults and patients aged 13 and older, and for agitation associated with Alzheimer's disease. It is not intended for as-needed treatment of agitation.
samsca
(tolvaptan)
Otsuka America Pharmaceutical, Inc.
Usage: SAMSCA® is indicated for treating clinically significant hypervolemic and euvolemic hyponatremia in patients, including those with heart failure and SIADH. It is not recommended for urgent serum sodium increases to prevent neurological symptoms, and its symptomatic benefits have not been established.
voyxact
(Sibeprenlimab)
Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. drugs

abilify

abilify maintena

abilify mycite

busulfex

jynarque

rexulti

samsca

voyxact